Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Zoom
ZM
|
+$1.14B |
| 2 |
AbbVie
ABBV
|
+$537M |
| 3 |
T-Mobile US
TMUS
|
+$504M |
| 4 |
Baidu
BIDU
|
+$474M |
| 5 |
Kroger
KR
|
+$448M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.32B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$504M |
| 5 |
Humana
HUM
|
+$466M |
Sector Composition
| 1 | Healthcare | 23.45% |
| 2 | Technology | 16.11% |
| 3 | Consumer Staples | 10.59% |
| 4 | Consumer Discretionary | 9.95% |
| 5 | Communication Services | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EMAN
3301
DELISTED
eMagin Corporation
EMAN
| $79K | ﹤0.01% |
99,800
-168,411
| -63% | -$133K |
|
3302
Boxlight
BOXL
$4.54M
| $77K | ﹤0.01% |
2,083
+1,665
| +398% | +$61.5K |
|
|
IMV
3303
DELISTED
IMV Inc. Common Shares
IMV
| $77K | ﹤0.01% |
+2,460
| New | +$77K |
|
3304
Rekor Systems
REKR
$140M
| $76K | ﹤0.01% |
+18,932
| New | +$76K |
|
|
NMTR
3305
DELISTED
9 Meters Biopharma, Inc. Common Stock
NMTR
| $74K | ﹤0.01% |
6,440
-4,830
| -43% | -$55.5K |
|
|
DNR
3306
DELISTED
Denbury Resources, Inc.
DNR
| $72K | ﹤0.01% |
+261,635
| New | +$72K |
|
3307
Avalon Holdings
AWX
$9.71M
| $71K | ﹤0.01% |
44,000
+10,900
| +33% | +$17.6K |
|
3308
SEACOR Marine Holdings
SMHI
$171M
| $70K | ﹤0.01% |
27,546
-10,115
| -27% | -$25.7K |
|
3309
Banco Bradesco
BBDO
$29B
| $69K | ﹤0.01% |
24,033
+6,087
| +34% | +$17.5K |
|
3310
Forum Energy Technologies
FET
$325M
| $69K | ﹤0.01% |
6,555
-30,716
| -82% | -$323K |
|
|
JFIN
3311
Jiayin Group
JFIN
$574M
| $69K | ﹤0.01% |
+17,758
| New | +$69K |
|
3312
CBAK Energy Technology
CBAT
$79.5M
| $68K | ﹤0.01% |
88,989
-2,260
| -2% | -$1.73K |
|
|
BDRX
3313
Biodexa Pharmaceuticals
BDRX
$3.55M
| – | – |
0
| – | -$27K |
|
3314
CASI Pharmaceuticals
CASI
$36.6M
| $67K | ﹤0.01% |
+2,680
| New | +$67K |
|
3315
CLPS Inc
CLPS
$28.5M
| $67K | ﹤0.01% |
+30,816
| New | +$67K |
|
|
PME
3316
DELISTED
Pingtan Marine Enterprise Ltd.
PME
| $66K | ﹤0.01% |
+57,287
| New | +$66K |
|
|
KRKR
3317
36Kr Holdings
KRKR
$16.8M
| $64K | ﹤0.01% |
+964
| New | +$64K |
|
|
HURA
3318
TuHURA Biosciences, Inc. Common Stock
HURA
$119M
| $63K | ﹤0.01% |
52
+45
| +643% | +$54.5K |
|
3319
Ocugen
OCGN
$325M
| $62K | ﹤0.01% |
279,669
-407,845
| -59% | -$90.4K |
|
3320
US Energy Corp
USEG
$39.8M
| $62K | ﹤0.01% |
+12,060
| New | +$62K |
|
|
GMO
3321
DELISTED
General Moly, Inc.
GMO
| $62K | ﹤0.01% |
306,741
+268,846
| +709% | +$54.3K |
|
3322
Geron
GERN
$823M
| $61K | ﹤0.01% |
+28,176
| New | +$61K |
|
3323
Hoth Therapeutics
HOTH
$21.3M
| $61K | ﹤0.01% |
+950
| New | +$61K |
|
3324
Siebert Financial
SIEB
$108M
| $61K | ﹤0.01% |
12,100
+700
| +6% | +$3.53K |
|
3325
Paramount Gold Nevada
PZG
$73.6M
| $60K | ﹤0.01% |
+48,180
| New | +$60K |
|